LU74175A1 - - Google Patents

Info

Publication number
LU74175A1
LU74175A1 LU74175A LU74175A LU74175A1 LU 74175 A1 LU74175 A1 LU 74175A1 LU 74175 A LU74175 A LU 74175A LU 74175 A LU74175 A LU 74175A LU 74175 A1 LU74175 A1 LU 74175A1
Authority
LU
Luxembourg
Application number
LU74175A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74175A1 publication Critical patent/LU74175A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LU74175A 1975-01-15 1976-01-13 LU74175A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (1)

Publication Number Publication Date
LU74175A1 true LU74175A1 (en:Method) 1977-03-18

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74175A LU74175A1 (en:Method) 1975-01-15 1976-01-13

Country Status (36)

Country Link
JP (1) JPS5946939B2 (en:Method)
AR (1) AR213088A1 (en:Method)
AT (1) AT362492B (en:Method)
BE (1) BE837600A (en:Method)
BR (1) BR7600206A (en:Method)
CA (1) CA1094549A (en:Method)
CH (1) CH631625A5 (en:Method)
CS (1) CS208147B2 (en:Method)
DD (1) DD124379A5 (en:Method)
DE (1) DE2600971C2 (en:Method)
DK (1) DK140801B (en:Method)
EG (1) EG11988A (en:Method)
ES (1) ES444558A1 (en:Method)
FI (1) FI66751C (en:Method)
FR (1) FR2297634A1 (en:Method)
GB (1) GB1524431A (en:Method)
GR (1) GR58608B (en:Method)
HU (1) HU175142B (en:Method)
IE (1) IE42395B1 (en:Method)
IL (1) IL48845A (en:Method)
IN (1) IN143279B (en:Method)
IT (1) IT1054211B (en:Method)
KE (1) KE2919A (en:Method)
LU (1) LU74175A1 (en:Method)
MX (1) MX4052E (en:Method)
MY (1) MY7900169A (en:Method)
NL (1) NL166464C (en:Method)
NO (1) NO146698C (en:Method)
NZ (1) NZ179733A (en:Method)
OA (1) OA05209A (en:Method)
PL (1) PL99927B1 (en:Method)
PT (1) PT64696B (en:Method)
RO (1) RO71576A (en:Method)
SE (1) SE437219B (en:Method)
YU (1) YU8376A (en:Method)
ZA (1) ZA7658B (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
PL3139979T3 (pl) 2014-05-07 2023-12-27 Boehringer Ingelheim International Gmbh Jednostka, nebulizator i sposób
TWI607770B (zh) 2014-05-07 2017-12-11 百靈佳殷格翰國際股份有限公司 噴霧器及其容器

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
PL99927B1 (pl) 1978-08-31
FI760058A7 (en:Method) 1976-07-16
FR2297634A1 (fr) 1976-08-13
JPS51125299A (en) 1976-11-01
AT362492B (de) 1981-05-25
NZ179733A (en) 1978-04-28
NO146698B (no) 1982-08-16
DE2600971A1 (de) 1976-07-22
HU175142B (hu) 1980-05-28
IL48845A0 (en) 1976-03-31
ATA21376A (de) 1980-10-15
PT64696B (fr) 1977-08-10
KE2919A (en) 1979-03-30
DD124379A5 (en:Method) 1977-02-16
DK8375A (en:Method) 1976-07-16
NO146698C (no) 1982-11-24
AU1030776A (en) 1977-07-21
MX4052E (es) 1981-11-24
IT1054211B (it) 1981-11-10
IN143279B (en:Method) 1977-10-29
DE2600971C2 (de) 1985-12-12
YU8376A (en) 1982-06-30
CH631625A5 (en) 1982-08-31
IE42395B1 (en) 1980-07-30
GR58608B (en) 1977-11-10
FI66751B (fi) 1984-08-31
NL166464C (nl) 1981-08-17
NL7600338A (nl) 1976-07-19
SE437219B (sv) 1985-02-18
IE42395L (en) 1976-07-15
FR2297634B1 (en:Method) 1979-03-30
DK140801C (en:Method) 1980-04-21
GB1524431A (en) 1978-09-13
AR213088A1 (es) 1978-12-15
EG11988A (en) 1978-06-30
ES444558A1 (es) 1977-05-16
IL48845A (en) 1981-06-29
BR7600206A (pt) 1976-08-31
DK140801B (da) 1979-11-19
CS208147B2 (en) 1981-08-31
FI66751C (fi) 1984-12-10
NO760118L (en:Method) 1976-07-16
RO71576A (ro) 1980-12-30
JPS5946939B2 (ja) 1984-11-15
NL166464B (nl) 1981-03-16
OA05209A (fr) 1981-02-28
MY7900169A (en) 1979-12-31
ZA7658B (en) 1976-12-29
PT64696A (fr) 1976-02-01
BE837600A (fr) 1976-07-15
CA1094549A (en) 1981-01-27
SE7600284L (sv) 1976-07-16

Similar Documents

Publication Publication Date Title
DK140801C (en:Method)
JPS5228025U (en:Method)
FR2319366B1 (en:Method)
JPS5419177Y2 (en:Method)
JPS5531989Y2 (en:Method)
JPS533520Y2 (en:Method)
JPS5532645Y2 (en:Method)
JPS5536970Y2 (en:Method)
JPS5343027B1 (en:Method)
JPS5646662B2 (en:Method)
JPS5284065U (en:Method)
JPS5280497U (en:Method)
JPS5279858U (en:Method)
JPS51136450U (en:Method)
JPS5236199U (en:Method)
JPS5191331U (en:Method)
CH611513A5 (en:Method)
CH606440A5 (en:Method)
CH611781A5 (en:Method)
CH605664A5 (en:Method)
CH611081A5 (en:Method)
CH610999A5 (en:Method)
CH608213A5 (en:Method)
CH607689A5 (en:Method)
CH596349B5 (en:Method)